medroxyprogesterone acetate has been researched along with Premature Birth in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S; Mishra, S; Singh, A; Singhania, S; Tandulwadkar, S | 1 |
| Fukuma, Y; Hamuro, A; Hasegawa, K; Ikenoue, S; Kasuga, Y; Ochiai, D; Oishi, M; Tamai, J; Tanaka, M; Tanaka, Y; Yamagami, W; Yoshimura, T | 1 |
| Ebner, CA; Elovitz, MA; Yellon, SM | 1 |
| Arcuri, F; Kayisli, UA; Lockwood, CJ; Murk, W; Norwitz, ER; Schatz, F; Snegovskikh, VV; Toti, P | 1 |
| Arcuri, F; Buchwalder, LF; Gopinath, A; Huang, SJ; Kayisli, UA; Li, M; Lockwood, CJ; Murk, WK; Schatz, F | 1 |
| Collins, JJ; Gavilanes, AW; Ikegami, M; Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Kuypers, E; Newnham, JP; Nitsos, I; Nowacki, R; Ofman, G; Pillow, JJ; Polglase, GR | 1 |
| Buchwalder, LF; Kayisli, UA; Lockwood, CJ; Murk, W; Schatz, F; Stocco, C; Vatandaslar, E | 1 |
| Bae, DS; Kim, JW; Kim, SM; Kim, TJ; Nam, JH; Park, JY; Seong, SJ | 1 |
| Delke, I; Kaunitz, AM; Sanchez-Ramos, L | 1 |
| Elovitz, MA; Mrinalini, C | 2 |
| Elovitz, MA; Gonzalez, JM; Ofori, E; Xu, H | 1 |
| Elovitz, MA; Gonzalez, J | 1 |
1 review(s) available for medroxyprogesterone acetate and Premature Birth
| Article | Year |
|---|---|
Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Confidence Intervals; Female; Follow-Up Studies; Gestational Age; Humans; Hydroxyprogesterones; Incidence; Medroxyprogesterone Acetate; Odds Ratio; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Treatment Outcome | 2005 |
1 trial(s) available for medroxyprogesterone acetate and Premature Birth
| Article | Year |
|---|---|
Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles.
Topics: Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infertility, Female; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Ovulation Induction; Premature Birth; Semen; Sperm Injections, Intracytoplasmic | 2023 |
11 other study(ies) available for medroxyprogesterone acetate and Premature Birth
| Article | Year |
|---|---|
Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study.
Topics: Adult; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Hospitals; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Obstetrics; Placenta Accreta; Pregnancy; Premature Birth; Retrospective Studies | 2023 |
Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth.
Topics: Animals; Cervical Ripening; Cervix Uteri; Collagen; Disease Models, Animal; Female; Gestational Age; Inflammation; Injections, Intramuscular; Lipopolysaccharides; Macrophages; Medroxyprogesterone Acetate; Mice; Nerve Fibers; Neutrophil Infiltration; Pregnancy; Premature Birth; Progestins | 2009 |
Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth.
Topics: Case-Control Studies; Cells, Cultured; Chorioamnionitis; Decidua; Estradiol; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Interleukin-1beta; Medroxyprogesterone Acetate; Neuropilin-1; Neuropilin-2; Pregnancy; Premature Birth; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2009 |
Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis.
Topics: Adult; Antineoplastic Agents, Hormonal; Blotting, Western; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chorioamnionitis; Decidua; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogens; Female; Gene Expression Regulation; Humans; Immunoenzyme Techniques; Interleukin-1beta; Interleukin-6; Medroxyprogesterone Acetate; Monocytes; Placenta; Pregnancy; Premature Birth; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs.
Topics: Amnion; Animals; Betamethasone; Bronchoalveolar Lavage Fluid; Chorioamnionitis; Cytokines; Female; Fetal Development; Fetal Organ Maturity; Gene Expression; Glucocorticoids; Inflammation; Lipopolysaccharides; Lung; Male; Medroxyprogesterone Acetate; Peroxidase; Phosphatidylcholines; Pregnancy; Premature Birth; Pulmonary Surfactant-Associated Protein C; Pulmonary Surfactant-Associated Protein D; Random Allocation; Sheep; Toll-Like Receptors | 2012 |
Abruption-induced preterm delivery is associated with thrombin-mediated functional progesterone withdrawal in decidual cells.
Topics: Abruptio Placentae; Blotting, Western; Cell Extracts; Cell Nucleus; Decidua; DNA; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Fluorescent Antibody Technique; Humans; MAP Kinase Signaling System; Medroxyprogesterone Acetate; Phosphorylation; Pregnancy; Premature Birth; Progesterone; Protein Binding; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Thrombin | 2012 |
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fertility Agents; Humans; Infant, Newborn; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Ectopic; Premature Birth; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?
Topics: Animals; Blotting, Western; Cervix Uteri; Female; Inflammation; Lipopolysaccharides; Medroxyprogesterone Acetate; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Placenta; Pregnancy; Premature Birth; Random Allocation; Receptors, Cell Surface; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptors; Uterus | 2005 |
The use of progestational agents for preterm birth: lessons from a mouse model.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; C-Reactive Protein; Female; Hydroxyprogesterones; Interleukin-10; Interleukin-6; Lipopolysaccharides; Medroxyprogesterone Acetate; Mice; Models, Animal; Pregnancy; Premature Birth; Progestins | 2006 |
Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?
Topics: Animals; Cervical Ripening; Cervix Uteri; Female; Medroxyprogesterone Acetate; Mice; Pregnancy; Premature Birth; Progestins; Protein Array Analysis | 2008 |
Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth.
Topics: Animals; Anti-Infective Agents, Local; Cervix Uteri; Cytokines; Disease Models, Animal; Female; Immunity, Cellular; Inflammation; Medroxyprogesterone Acetate; Mice; Placenta; Premature Birth | 2008 |